Free Disclosure Statement - District Court of Delaware - Delaware

Case 1:08-cv-00464-HB

Document 13

Filed 08/19/2008

Page 1 of 2

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
THE BRIGHAM AND WOMEN'S HOSPITAL, INC., NPS PHARMACEUTICALS, INC. and AMGEN INC., Plaintiffs, vs. TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICAL INDUSTRIES LTD. and BARR LABORATORIES, INC., Defendants. JURY TRIAL DEMANDED C.A. No. 08-464-HB

DEFENDANT BARR'S RULE 7.1 DISCLOSURE STATEMENT Defendant Barr Laboratories, Inc. makes the following disclosure pursuant to Federal Rule of Civil Procedure 7.1: Defendant Barr Laboratories, Inc. is a wholly-owned subsidiary of Barr Pharmaceuticals, Inc. Barr Pharmaceuticals, Inc. is publicly traded on the New York Stock Exchange under the ticker symbol BRL. To the best of our knowledge as of the date hereof, no publicly-held corporation or parent corporation currently owns 10% or more of Barr Pharmaceuticals' stock. However, Barr Pharmaceuticals recently entered into an agreement with Teva Pharmaceuticals, Inc. whereby Teva Pharmaceuticals has agreed to acquire 100% of Barr Pharmaceuticals' stock. It is expected that this agreement will be finalized sometime in the fourth quarter of 2008.

Case 1:08-cv-00464-HB

Document 13

Filed 08/19/2008

Page 2 of 2

Dated: August 19, 2008

/s/ Richard K. Herrmann Richard K. Herrmann (#405) Mary B. Matterer (#2696) MORRIS JAMES LLP 500 Delaware Avenue, Suite 1500 Wilmington, Delaware 19801 Telephone: (302) 888-6816 Fax: (302) 571-1750 Email: [email protected] Email: [email protected] George C. Lombardi Imron T. Aly Elizabeth H. Erickson WINSTON & STRAWN LLP 35 West Wacker Drive Chicago, Illinois 60601 Telephone: (312) 558-5600 Fax: (312) 558-5700 Email: [email protected] Email: [email protected] Email: [email protected] Attorneys for Defendant Barr Laboratories, Inc.

2